Back
FibroGen Vs. Merck & Industry Stock Comparison
Buy
55
FGEN
FibroGen
Last Price:
$0.55
Seasonality Move:
1.68%
Sell
32
MRK
Merck &
Last Price:
$99.61
Seasonality Move:
0.15%
Sell
32
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
-
MRK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FGEN Stock Price Chart
FGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 61.8 | Buy |
Chaikin Money Flow: | -316926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.59) | Buy |
Bollinger Bands (100): | (0.32 - 0.48) | Buy |
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 52.98 | Buy |
Chaikin Money Flow: | 6817142 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.73 - 101.73) | Buy |
Bollinger Bands (100): | (99.53 - 113.93) | Sell |
FGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.59 | Sell |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.41 | Buy |
200-day SMA: | 0.76 | Sell |
8-day EMA: | 0.59 | Sell |
20-day EMA: | 0.52 | Buy |
50-day EMA: | 0.46 | Buy |
200-day EMA: | 1.01 | Sell |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 99.83 | Buy |
20-day SMA: | 99.73 | Buy |
50-day SMA: | 100.33 | Buy |
200-day SMA: | 116.48 | Sell |
8-day EMA: | 99.95 | Buy |
20-day EMA: | 99.99 | Buy |
50-day EMA: | 101.78 | Sell |
200-day EMA: | 110.77 | Sell |
FibroGen Earnings Growth & FGEN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.18 per share.
Merck & Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and an increase next year of $0.99 per share.
FibroGen Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merck & Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |